MANKIND PHARMA
Back to All Ratios
|
MANKIND PHARMA Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Core EBITDA Growth(%) | 27.25 | 37.67 | -7.14 | 20.14 | 17.54 |
What is the latest Core EBITDA Growth ratio of MANKIND PHARMA ?
Year | Core EBITDA Growth |
---|---|
Mar2025 | 27.25 |
Mar2024 | 37.67 |
Mar2023 | -7.14 |
Mar2022 | 20.14 |
Mar2021 | 17.54 |
How is Core EBITDA Growth of MANKIND PHARMA Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2025 | 27.25 | -27.66 | |
Mar2024 | 37.67 | Positive | |
Mar2023 | -7.14 | Negative | |
Mar2022 | 20.14 | 14.82 | |
Mar2021 | 17.54 | - |
Other Financial Ratios of MANKIND PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹105,372.6 Cr | -0.6% | 5.1% | 31.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,478.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,845.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
CIPLA | ₹120,121.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,327.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,907.8 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -0.6% |
5.1% |
31.5% |
SENSEX | -1.2% |
-3.5% |
-0.5% |
You may also like the below Video Courses